AdvisorShares Psychedelics ETF
PSILNYSEARCAAdvisorSharesEquity
As of Oct 23, 2026 close
- Assets (AUM)
- $49.85M
- Expense ratio
- 1.00%
- Dividend yield
- 8.05%
- Holdings
- 35
- 52-week range
- $15.64$27.02
- Volume (live)
- -
- Avg. volume (3M)
- 26.53K
PSIL ETF: AdvisorShares Psychedelics ETF - Price, Holdings & Analysis
AdvisorShares Psychedelics ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $20.30 - $20.69 |
|---|---|
| 52-Week High | $27.02 |
| 52-Week Low | $15.64 |
| Open | $20.30 |
| Volume (last close) | 22.88K |
| Average Volume (3M) | 26.53K |
| 1 Day Change | −0.43% |
|---|---|
| 1 Month Change | −12.97% |
| 6 Month Change | +4.08% |
| YTD Change | +21.69% |
| 1 Year Change | +7.74% |
| 5 Year Change | −77.24% |
| Annual Dividend | $1.68 |
|---|---|
| Dividend Yield | 8.05% |
| Last Dividend Ex-Date | Dec 22, 2025 |
| Dividend Growth YoY | +572.98% |
| Years Dividend Growth | 2 |
| Assets (AUM) | $49.85M |
|---|---|
| Expense Ratio | 1.00% |
| Total Holdings | 35 |
| Inception Date | Sep 14, 2021 |
| 50-Day MA | $23.82 |
|---|---|
| 200-Day MA | $20.59 |
| RSI | 41.28 |
| Stochastic %K | 45.09 |
| Stochastic %D | 18.32 |
Source: Exchange price data and fund disclosures. Data as of Oct 23, 2026. Data sources and methodology
PSIL at a Glance
AdvisorShares Psychedelics ETF (PSIL) is an equity ETF from AdvisorShares, launched in September 2021. It manages $49.85M in assets and charges a 1.00% expense ratio, about $100 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 35 positions. The largest are Definium Therapeutics, Inc. (DFTX, 11.82%), ATAI Life Sciences BV (ATAI, 11.50%) and COMPASS Pathways plc (CMPS, 11.45%). The top 10 holdings make up 72.0% of the fund. By sector it leans toward Healthcare (100.0%). Its largest country exposures are United States (76.9%), United Kingdom (8.6%) and Canada (6.9%).
It pays distributions yielding 8.05% at the Oct 23, 2026 close, $1.68 per share over the trailing 12 months. As of the Oct 23, 2026 close, the share price is up 7.7% over one year and down 77.2% over five years (price change, excluding distributions).
Frequently Asked Questions About AdvisorShares Psychedelics ETF
What is the current price of PSIL?
The latest PSIL price is $20.64 (Oct 23, 2026 close). The 52-week range is $15.63–$27.02. The share price is up 7.7% over the past year (price change, excluding distributions).
What is the expense ratio for PSIL?
PSIL's annual expense ratio is 1.00%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does PSIL pay dividends?
Yes, PSIL pays a 8.05% dividend yield (trailing 12 months, at the Oct 23, 2026 close). The most recent ex-dividend date was December 22, 2025. View full dividend history in the Dividends section.
What are the top holdings of PSIL?
As of Oct 4, 2026, PSIL's largest holdings are Definium Therapeutics, Inc. (11.8%), ATAI Life Sciences BV (11.5%), COMPASS Pathways plc (11.4%) (combined weight: 34.8%). The fund holds 35 total positions. View the complete portfolio breakdown in the Holdings section.
How does PSIL compare to similar ETFs?
Compare PSIL (1.00% expense ratio, $50M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.